Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | X025908 | — |
No other AE; inadvertent administration of an expired dose of VAQTA to a patient; This invalid spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-May-2025, the patient was vaccinated with a dose of Hepatitis A Vaccine, Inactivated (VAQTA) lot #X025908, expiration date reported as and upon internal validation confirmed to be: 24-Apr-2025) (dose, route of administration and vaccination site were not reported) administered for prophylaxis. On that day, an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) was inadvertently administered to the patient (expired product administered). No symptoms were reported and no additional details were provided. No other adverse event (AE) and no product quality complaint (PQC) was reported (no adverse event). This case was considered to be invalid due to lack of patient's identifiers.